ReWalk Robotics Ltd. (NASDAQ:RWLK) is set to announce third quarter earning results on Tuesday 10th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, RWLK to report 3Q20 loss of $ 0.16 per share.
For the full year, analysts anticipate top line of $ 5.00 million, while looking forward to loss of $ 0.82 per share bottom line.
Previous Quarter Performance
ReWalk Robotics Ltd. reported loss for the second quarter of $ 0.22 per share, from the revenue of $ 1.67 million. The quarterly revenues decreased 33.20 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.27 per share from $ 0.80 million in revenue. The bottom line results beat street analysts by $ 0.05 or 18.52 percent, at the same time, top line results outshined analysts by $ 0.87 million or 108.75 percent.
Stock Performance
Shares of ReWalk Robotics Ltd. traded up $ 0.03 or 2.61 percent on Monday, reaching $ 1.18 with volume of 377.00 thousand shares. ReWalk Robotics Ltd. has traded high as $ 1.23 and has cracked $ 1.13 on the downward trend
According to the previous trading day, closing price of $ 1.18, representing a 180.49 % increase from the 52 week low of $ 0.41 and a 61.67 % decrease over the 52 week high of $ 3.00.
The company has a market capital of $ 22.61 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
ReWalk Robotics Ltd. will be hosting a conference call at 8:30 AM eastern time on 10th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.rewalk.com
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke.
